Ursula Wiedermann
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Vaccination policies for healthcare personnel in Europe, 2026.
Journal: Vaccine
Published: May 11, 2026
Gnotobiotic mouse models as tools for dissecting the role of the microbiota in allergy: contributions from the laboratory of gnotobiology in Nový Hrádek.
Journal: Folia microbiologica
Published: April 21, 2026
Lignin/alginate biomaterials as a promising complementary approach in ocular chlamydial infection.
Journal: Frontiers in cellular and infection microbiology
Published: March 30, 2026
Extracellular vesicles as indicators of environmental stress response in Lactiplantibacillus plantarum.
Journal: Extracellular vesicles and circulating nucleic acids
Published: February 19, 2026
Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination-A Population-Based Study of 3066 Individuals.
Journal: Influenza and other respiratory viruses
Published: February 19, 2026
Antibacterial effects of coniferyl alcohol-derived dehydrogenation polymer on chlamydial infection in vitro.
Journal: Frontiers in chemistry
Published: June 26, 2025
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults.
Journal: Vaccines
Published: June 12, 2025
Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trial.
Journal: The Journal of infection
Published: September 25, 2024
Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccine.
Journal: PLoS neglected tropical diseases
Published: September 09, 2024
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines.
Journal: Vaccines
Published: July 23, 2024
Last Updated: 09/26/2026